NCT05213832View on ClinicalTrials.gov

Effect of Inhalatory Sedation in Subarachnoid Hemorrhage

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 26, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Subarachnoid HemorrhageAneurysmal Subarachnoid Hemorrhage
Interventions
DRUG

Isoflurane Inhal Soln

Administration of isofluorane in patients with severe SAH

Trial Locations (1)

10126

AOU Città della Salute e della Scienza - Presidio CTO, Torino

All Listed Sponsors
lead

A.O.U. Città della Salute e della Scienza

OTHER

NCT05213832 - Effect of Inhalatory Sedation in Subarachnoid Hemorrhage | Biotech Hunter | Biotech Hunter